Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.962 USD | +6.49% | +3.04% | -29.80% |
05-29 | Bluebird bio, Inc. Announces Executive Changes, Effective from June 10, 2024 | CI |
05-29 | Bluebird bio, Inc. Announces Chief Financial Officer Changes, Effective June 10, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.80% | 174M | |
+15.68% | 118B | |
+12.45% | 106B | |
-2.96% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-19.61% | 15.56B | |
+6.08% | 13.63B | |
+28.89% | 12.27B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Bluebird Bio : Bristol-Myers Secure FDA Approval For Blood Cancer Drug Abecma